-
1دورية أكاديمية
المؤلفون: Aleckovic, M, Cristea, S, Del Alcazar, CRG, Yan, PZ, Ding, LN, Krop, ED, Harper, NW, Jimenez, ER, Lu, DH, Gulvady, AC, Foidart, P, Seehawer, M, Diciaccio, B, Murphy, KC, Pyrdol, J, Anand, J, Garza, K, Wucherpfennig, KW, Tamimi, RM, Michor, F, Polyak, K
المصدر: Nature communications. 13(1):7558
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديميةHuman WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation.
المؤلفون: Cai WL; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, United States.; Department of Pathology, Yale University, New Haven, United States., Chen JF; Department of Pathology, Yale University, New Haven, United States., Chen H; Department of Pathology, Yale University, New Haven, United States., Wingrove E; Department of Pathology, Yale University, New Haven, United States., Kurley SJ; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States., Chan LH; Department of Pathology, Yale University, New Haven, United States., Zhang M; Department of Pathology, Yale University, New Haven, United States., Arnal-Estape A; Department of Pathology, Yale University, New Haven, United States.; Yale Cancer Center, Yale School of Medicine, New Haven, United States., Zhao M; Department of Pathology, Yale University, New Haven, United States., Balabaki A; Department of Pathology, Yale University, New Haven, United States., Li W; Yale Cancer Biology Institute, Department of Pharmacology, Yale University, West Haven, United States., Yu X; Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States.; Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States., Krop ED; Department of Pathology, Yale University, New Haven, United States.; Department of Biosciences, Rice University,, Houston, United States., Dou Y; Department of Pathology, University of Michigan, Ann Arbor, Ann Arbor, United States.; Department of Medicine, Department of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, United States., Liu Y; Yale Cancer Center, Yale School of Medicine, New Haven, United States.; Yale Cancer Biology Institute, Department of Pharmacology, Yale University, West Haven, United States., Jin J; Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States.; Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States., Westbrook TF; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States., Nguyen DX; Department of Pathology, Yale University, New Haven, United States.; Yale Cancer Center, Yale School of Medicine, New Haven, United States.; Yale Stem Cell Center, Yale School of Medicine, New Haven, United States.; Department of Internal Medicine (Section of Medical Oncology), Yale School of Medicine,, New Haven, United States., Yan Q; Department of Pathology, Yale University, New Haven, United States.; Yale Cancer Center, Yale School of Medicine, New Haven, United States.; Yale Stem Cell Center, Yale School of Medicine, New Haven, United States.; Yale Center for Immuno-Oncology, Yale School of Medicine, New Haven, United States.
المصدر: ELife [Elife] 2022 Aug 31; Vol. 11. Date of Electronic Publication: 2022 Aug 31.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Gil Del Alcazar CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Rojas Jimenez E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Oliphant MUJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Xie S; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Krop ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lulseged B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Keenan TE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Dillon DA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Muthuswamy SK; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts.; Harvard Stem Cell Institute, Cambridge, Massachusetts.
المصدر: Cancer immunology research [Cancer Immunol Res] 2022 Jun 03; Vol. 10 (6), pp. 680-697.
نوع المنشور: Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Journal Article; Comment
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/immunology , Breast Neoplasms*/therapy, Animals ; Female ; Hormones ; Humans ; Immunologic Factors ; Immunotherapy ; Mice ; Rats ; Rats, Sprague-Dawley ; Receptors, Antigen, T-Cell